EUVIMEDEUVIMED entdecken
Crossref

Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemotherapy with anti-PD-1 therapy

Kai Chen, Yongsu Ma, Xinxin Liu, Xiejian Zhong, Di Long, Xiaodong Tian, Lei Zheng, Yinmo Yang

Cancer Letters · 2023

DOI: 10.1016/j.canlet.2023.216421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Kai Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking University First Hospital, Beijing, 100034, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University Health Science Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating evidence suggests the minority of patients with advanced pancreatic ductal adenocarcinoma (PDAC) that have microsatellite instability high (MSI-H) can benefit from immune checkpoint inhibitors (ICIs). However, the effects of ICIs on the tumor microenvironment (TME) of PDAC remain elusive. We conducted single-cell RNA-seq (scRNA-seq) analysis on a residual lesion from a MSI-H PDAC patient who received a radical operation after eight cycles of neoadjuvant treatment (nab-paclitaxel/gemcitabine plus pembrolizumab). Multiple tumor subclusters were identified in residual lesion after neoadjuvant treatment, one of which was mainly composed of cells in the S and G2M phases. This subcluster also had enriched expression of MKI67 and PCNA and cell cycle-related signatures and was thus defined as a proliferating tumor subcluster. This subcluster had higher S_score, Fatty acid_score, UPR_score, and Glycolysis_score than others. We also identified characteristics of the TME after neoadjuvant treatment by comparing the excised primary tumors form nontreated PDAC and the residual lesion. The residual lesion was characterized with activated pancreatic stellate cells (PSCs) and exhausted T cells (Tex). We compared the receptor-ligand interactions between the two groups, and found that no checkpoint receptor-ligand pairs between T cells and tumor cells were identified in the residual lesion, while there were many checkpoint receptor-ligand pairs in the nontreated primary PDAC. In conclusion, our findings revealed the characteristics of residual lesion of advanced PDAC with MSI-H upon combination treatment of chemotherapy and immunotherapy, which might provide some valuable clues for solving the puzzle of ICI in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansNeoadjuvant TherapyTumor MicroenvironmentMicrosatellite InstabilityLigandsSingle-Cell Gene Expression Analysis

Stichwörter der Autor:innen

ImmunotherapyMSI-HPancreatic cancerScRNA-seqTumor microenvironment

Substanzen

Ligands

Autor:innen und Institutionen

  • Department of General Surgery, Peking University First Hospital, Beijing, 100034, China.
  • Department of General Surgery, Peking University First Hospital, Beijing, 100034, China. Electronic address: tianxiaodong@pkufh.com.
  • Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA; The…
  • Department of General Surgery, Peking University First Hospital, Beijing, 100034, China. Electronic address: YangyinmoSCI@bjmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Peking University Health Science Center

Zitieren

APA

Chen, K., Ma, Y., Liu, X., Zhong, X., Long, D., Tian, X., Zheng, L., & Yang, Y. (2023). Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemotherapy with anti-PD-1 therapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216421

Vancouver

Chen K, Ma Y, Liu X, Zhong X, Long D, Tian X, et al. Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemotherapy with anti-PD-1 therapy. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216421

BibTeX
@article{Chen2023,
  author = {Chen, Kai and Ma, Yongsu and Liu, Xinxin and Zhong, Xiejian and Long, Di and Tian, Xiaodong and Zheng, Lei and Yang, Yinmo},
  title = {Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemotherapy with anti-PD-1 therapy},
  journal = {Cancer Letters},
  year = {2023},
  doi = {10.1016/j.canlet.2023.216421}
}
Kostenlos starten →